Thrombelastograph analysis after heparin neutralization with protamine and heparinase during cardiopulmonary bypass

C. Forst, James William Chapin, S. Forst, A. Stammers, T. Galbraith

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Hemostatic disorders generated during cardiopulmonary bypass (CPB) result in postsurgical hemorrhage, a major cause of morbidity in cardiac patients. Thrombelastography (TEG) monitors elastokinetic whole blood coagulation but is sensitive to low quantities of circulating heparin, obviating its use during CPB. Heparinase is an enzyme that degrades heparin without affecting coagulation proteins that may aid in identifying coagulopathies during CPB. In the present study two methods of neutralizing heparin were used to generate TEG profiles during CPB. These profiles were generated by adding 0.03 ml protamine (0.0134 mg) or heparinase (6 U) 0.33 ml samples of heparinized blood. Samples were drawn pre-CPB, 10 and 30 minutes after initiation of CPB, 5 minutes after administration of protamine and 10 minutes after administration of platelet-rich-plasma, from 11 patients undergoing cardiac surgery. The results indicate a significantly higher baseline reaction time between pre-CPB in both groups when compared to all other time points (p < 0.007). During CPB, both protamine and heparinase reversed the anticoagulant effect of heparin, permitting the generation of useful TEG data. We therefore conclude that intraoperative TEG profiles can be produced during CPB for the purpose of identifying hemostatic conditions prior to termination of extracorporeal circulation.

Original languageEnglish (US)
Pages (from-to)129-134
Number of pages6
JournalJournal of Extra-Corporeal Technology
Volume26
Issue number3
StatePublished - Jan 1 1994

Fingerprint

Heparin Lyase
Protamines
Cardiopulmonary Bypass
Heparin
Thrombelastography
Hemostatic Disorders
Platelet-Rich Plasma
Extracorporeal Circulation
Blood Coagulation
Hemostatics
Anticoagulants
Thoracic Surgery
Reaction Time
Hemorrhage
Morbidity

ASJC Scopus subject areas

  • Medicine (miscellaneous)

Cite this

Thrombelastograph analysis after heparin neutralization with protamine and heparinase during cardiopulmonary bypass. / Forst, C.; Chapin, James William; Forst, S.; Stammers, A.; Galbraith, T.

In: Journal of Extra-Corporeal Technology, Vol. 26, No. 3, 01.01.1994, p. 129-134.

Research output: Contribution to journalArticle

@article{7d35035660304518aaebf16c8ab5af59,
title = "Thrombelastograph analysis after heparin neutralization with protamine and heparinase during cardiopulmonary bypass",
abstract = "Hemostatic disorders generated during cardiopulmonary bypass (CPB) result in postsurgical hemorrhage, a major cause of morbidity in cardiac patients. Thrombelastography (TEG) monitors elastokinetic whole blood coagulation but is sensitive to low quantities of circulating heparin, obviating its use during CPB. Heparinase is an enzyme that degrades heparin without affecting coagulation proteins that may aid in identifying coagulopathies during CPB. In the present study two methods of neutralizing heparin were used to generate TEG profiles during CPB. These profiles were generated by adding 0.03 ml protamine (0.0134 mg) or heparinase (6 U) 0.33 ml samples of heparinized blood. Samples were drawn pre-CPB, 10 and 30 minutes after initiation of CPB, 5 minutes after administration of protamine and 10 minutes after administration of platelet-rich-plasma, from 11 patients undergoing cardiac surgery. The results indicate a significantly higher baseline reaction time between pre-CPB in both groups when compared to all other time points (p < 0.007). During CPB, both protamine and heparinase reversed the anticoagulant effect of heparin, permitting the generation of useful TEG data. We therefore conclude that intraoperative TEG profiles can be produced during CPB for the purpose of identifying hemostatic conditions prior to termination of extracorporeal circulation.",
author = "C. Forst and Chapin, {James William} and S. Forst and A. Stammers and T. Galbraith",
year = "1994",
month = "1",
day = "1",
language = "English (US)",
volume = "26",
pages = "129--134",
journal = "Journal of Extra-Corporeal Technology",
issn = "0022-1058",
publisher = "American Society of Extra-Corporeal Technology",
number = "3",

}

TY - JOUR

T1 - Thrombelastograph analysis after heparin neutralization with protamine and heparinase during cardiopulmonary bypass

AU - Forst, C.

AU - Chapin, James William

AU - Forst, S.

AU - Stammers, A.

AU - Galbraith, T.

PY - 1994/1/1

Y1 - 1994/1/1

N2 - Hemostatic disorders generated during cardiopulmonary bypass (CPB) result in postsurgical hemorrhage, a major cause of morbidity in cardiac patients. Thrombelastography (TEG) monitors elastokinetic whole blood coagulation but is sensitive to low quantities of circulating heparin, obviating its use during CPB. Heparinase is an enzyme that degrades heparin without affecting coagulation proteins that may aid in identifying coagulopathies during CPB. In the present study two methods of neutralizing heparin were used to generate TEG profiles during CPB. These profiles were generated by adding 0.03 ml protamine (0.0134 mg) or heparinase (6 U) 0.33 ml samples of heparinized blood. Samples were drawn pre-CPB, 10 and 30 minutes after initiation of CPB, 5 minutes after administration of protamine and 10 minutes after administration of platelet-rich-plasma, from 11 patients undergoing cardiac surgery. The results indicate a significantly higher baseline reaction time between pre-CPB in both groups when compared to all other time points (p < 0.007). During CPB, both protamine and heparinase reversed the anticoagulant effect of heparin, permitting the generation of useful TEG data. We therefore conclude that intraoperative TEG profiles can be produced during CPB for the purpose of identifying hemostatic conditions prior to termination of extracorporeal circulation.

AB - Hemostatic disorders generated during cardiopulmonary bypass (CPB) result in postsurgical hemorrhage, a major cause of morbidity in cardiac patients. Thrombelastography (TEG) monitors elastokinetic whole blood coagulation but is sensitive to low quantities of circulating heparin, obviating its use during CPB. Heparinase is an enzyme that degrades heparin without affecting coagulation proteins that may aid in identifying coagulopathies during CPB. In the present study two methods of neutralizing heparin were used to generate TEG profiles during CPB. These profiles were generated by adding 0.03 ml protamine (0.0134 mg) or heparinase (6 U) 0.33 ml samples of heparinized blood. Samples were drawn pre-CPB, 10 and 30 minutes after initiation of CPB, 5 minutes after administration of protamine and 10 minutes after administration of platelet-rich-plasma, from 11 patients undergoing cardiac surgery. The results indicate a significantly higher baseline reaction time between pre-CPB in both groups when compared to all other time points (p < 0.007). During CPB, both protamine and heparinase reversed the anticoagulant effect of heparin, permitting the generation of useful TEG data. We therefore conclude that intraoperative TEG profiles can be produced during CPB for the purpose of identifying hemostatic conditions prior to termination of extracorporeal circulation.

UR - http://www.scopus.com/inward/record.url?scp=0027994250&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027994250&partnerID=8YFLogxK

M3 - Article

VL - 26

SP - 129

EP - 134

JO - Journal of Extra-Corporeal Technology

JF - Journal of Extra-Corporeal Technology

SN - 0022-1058

IS - 3

ER -